Financhill
Back

EyePoint Pharmaceuticals Vs. Editas Medicine Industry Stock Comparison

Buy
56

EYPT
EyePoint Pharmaceuticals

Last Price:
12.05
Seasonality Move:
19.48%
Sell
49

EDIT
Editas Medicine

Last Price:
3.28
Seasonality Move:
21.39%
Buy
56
EyePoint Pharmaceuticals (EYPT) is a Buy

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $11.61. The Score for EYPT is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • EYPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $3.12. The Score for EDIT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $11.61
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $3.12
    The current trend is relatively stagnant and EDIT is experiencing buying pressure, which is a positive indicator for future bullish movement.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.78 Buy
Relative Strength Index (14 RSI): 61.26 Buy
Chaikin Money Flow: 288172 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.64 - 11.44) Buy
Bollinger Bands (100): (8.05 - 10.13) Buy

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 45.93 Sell
Chaikin Money Flow: 1568900 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.01 - 3.39) Sell
Bollinger Bands (100): (3.3 - 4.98) Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.47 Buy
20-day SMA: 10.45 Buy
50-day SMA: 9.29 Buy
200-day SMA: 14.61 Sell
8-day EMA: 11.42 Buy
20-day EMA: 10.64 Buy
50-day EMA: 9.83 Buy
200-day EMA: 11.64 Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.05 Buy
20-day SMA: 3.18 Sell
50-day SMA: 3.44 Sell
200-day SMA: 5.51 Sell
8-day EMA: 3.05 Buy
20-day EMA: 3.18 Sell
50-day EMA: 3.51 Sell
200-day EMA: 5.28 Sell

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.83 per share.

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.37 per share, and an increase next year of $0.05 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):